Wird geladen...
Use of onabotulinumtoxinA for overactive bladder with concomitant warfarin
Overactive bladder symptoms (OAB) can be treated with oral medications using a variety of antimuscarinic medications and more recently mirabegron, a beta-3 agonist. However, the use of these medications may be limited for patients due to adverse drug reactions, contraindications, and those who are r...
Gespeichert in:
| Veröffentlicht in: | Consult Pharm |
|---|---|
| Hauptverfasser: | , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
2014
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4605390/ https://ncbi.nlm.nih.gov/pubmed/25203108 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4140/TCP.n.2014.480 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|